Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery

Journal of Bone and Joint Surgery - Series B

Volumn 85, Issue 1, 2003, Pages 107-114

  Bacci, G ^a   Ferrari, S ^a   Longhi, A ^a   Versari, M ^a   Forni, C ^a   Donati, D ^a   Manfrini, M ^a   Trentani, P ^a   Barbieri, E ^b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOMYOPATHY; CHILD; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EWING SARCOMA; FEMALE; FEMUR TUMOR; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; LIMB AMPUTATION; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FEMUR; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SARCOMA, EWING'S; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037272819     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.85B1.12781     Document Type: Review

References (31)

1. Bacci G, Toni A, Avella M, et al. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 1989;63:1477-86.
2. Bacci G, Picci P, Ferrari S, et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide and doxorubicin in the maintenance phase - results of two sequential studies. Cancer 1998;82:1174-83.
3. Burgert EO, Nesbit ME, Garnsey LA, et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study ESS-II. J Clin Oncol 1990;8:1514-24.
4. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000;18:3108-14.
5. Jurgens H, Exner U, Gadner H, et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone: a 6-year experience of a European Cooperative Trial. Cancer 1988;61:23-32.
6. Nesbit ME, Gehan EA, Burgert EO, et al. Multimodal therapy for the management of primary nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol 1990;8:1664-74.
7. Oberlin O, Patte C, Demeocq F, et al. The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma. Eur J Cancer Clin Oncol 1985;21:463-7.
8. Paulussen M, Ahrens S, Dunst J, et al. Localized Ewing tumor of bone: final results of the Cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001;19:1818-29.
9. Rosito P, Mancini AF, Rondelli R, et al. Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience. Cancer 1999;86:421-8.
10. Ferrari S, Mercuri M, Rosito P, et al. Ifosfamide and Actinomycin-D added in the induction phase to Vincristine, Cyclophosphamide and Doxorubicin, improve histologic response and prognosis in patients with non-metastatic Ewing's sarcoma of the extremity. J Chemother 1998;10:484-91.
11. Wilkins RM, Pritchard DJ, Omer Burgert E, Unni KK. Ewing's sarcoma of bone: experience with 140 patients. Cancer 1986;58:2551-5.
12. Dunst J, Hoffmann C, Ahrens S, Jurgens H. Surgery versus radiotherapy in Ewing's sarcoma with good prognosis: analysis of the CESS 86 data. Strahlenther Onkol 1996;172:244-8.
13. Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol 2000;18:4-11.
14. Ozaki T, Hillmann A, Hoffmann C, et al. Ewing's sarcoma of the femur: prognosis in 69 patients treated by the CESS group. Acta Orthop Scand 1997;68:20-4.
15. Terek RM, Brien EW, Marcove RC, et al. Treatment of femoral Ewing's sarcoma. Cancer 1996;78:70-8.
16. Gobel V, Jurgens H, Etspuler G, et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 1987;113:187-91.
17. Barbieri E, Frezza G, Martelli O, et al. Non-conventional fractionation in radiotherapy of the musculo-skeletal sarcomas. Tumori 1998;84:167-70.
18. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980;153:106-20.
19. Picci P, Bohling T, Bacci G, et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 1997;15:1553-9.
20. Enneking WF. Modification of the system for functional evaluation of surgical management of musculoskeletal oncology. In: Musculoskeletal tumor surgery. New York: Churchill-Livingstone, 1987.
21. Boyer CW, Brickner TJ, Perry RH. Ewing's sarcoma: case against surgery. Cancer 1967;20:1602-6.
22. Larsson SE, Boquist L, Bergdahl L. Ewing's sarcoma: a consecutive series of 64 cases diagnosed in Sweden 1958-1967. Clin Orthop 1973;95:263-72.
23. Wang CC, Schultz MD. Ewing's sarcoma: a study of fifty cases treated at the Massachusetts General Hospital. N Engl J Med 1953;248:571-6.
24. Springfield DS, Pagliarulo C. Fractures of long bones previously treated for Ewing's sarcoma. J Bone Joint Surg [Am] 1985;67-A:477-81.
25. Tefft M, Lattin PB, Jereb B, et al. Acute and late effects on normal tissues following combined chemo- and radiotherapy for childhood rhabdomyosarcoma and Ewing's sarcoma. Cancer 1976;37:(2 Suppl) 1201-17.
26. Li P, Cassady JR, Jaffe N. Risk of second tumors in survivors of childhood cancer. Cancer 1975;35:1230-5.
27. Nicholson HS, Mulvihill JJ, Byrne J. Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarcoma. Med Pediatr Oncol 1992;20:6-12.
28. Strong LC, Herson J, Osborne BM, Sutow WW. Risk of radiation-related subsequent malignant tumors in survivors of Ewing's sarcoma. J Natl Cancer Inst 1979;62:1401-6.
29. Kuttesch JF, Wexler LH, Marcus RB, et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996;14:2818-25.
30. Wunder JS, Paulian G, Huvos AG, et al. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing's sarcoma. J Bone Joint Surg [Am] 1998;80-A:1020-33.
31. Damron TA, Sim FH, O'Connor MI, Pritchard DJ, Smithson WA. Ewing's sarcoma of the proximal femur. Clin Orthop 1996;322:232-44.